Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monitoring of influenza-like symptoms among elderly (CAPiTA follow-up)
2010-022682-98Phase 4Active
- Sponsor
- Julius Center for Health Sciences and Primary Care
- Start
- Sep 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of pneumococcal 13-valent conjugate vaccine in influenza-like illness (ILI) and pulmonary infection (2 arms), sponsored by Julius Center for Health Sciences and Primary Care. Primary endpoint: Incidence of a first episode of self-reported influenza-like illness (ILI). Started Sep 2010; status: active.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
influenza-like illness (ILI)pulmonary infection
Beyond the preview
Go deeper on 2010-022682-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022682-98.